1. Home >
  2. M&A >
  3. Growth Capital >
  4. United Kingdom >
  5. Foresight Private Equity Invests In AMT

Investment Summary

Foresight Private Equity Invests In AMT

On October 23, 2019, private equity firm Foresight Private Equity invested in machinery company AMT

Investment Highlights
  • This is Foresight Private Equity’s 2nd transaction in the Machinery sector.
  • This is Foresight Private Equity’s 112th transaction in the United Kingdom.

Investment Summary
Date 2019-10-23
Target AMT
Sector Machinery
Investor(s) Foresight Private Equity
Deal Type Growth Capital

Target

AMT

Sheffield, United Kingdom
AMT is a developer of technology designed to unlock the potential of industrial additive manufacturing. AMT set up with the aim of developing industrial technologies to enable the deployment of 3D printing for mass production, especially to address the shortcomings of existing post-processing technologies. AMT was founded in 2017 and is based in Sheffield, United kingdom.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Foresight Private Equity

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1984
PE ASSETS 1.4B GBP
Size Large
Type Sector Agnostic
DESCRIPTION

Foresight Group LLP (Formerly VCF Partners)

DEAL STATS #
Overall 116 of 208
Sector: Machinery M&A 2 of 3
Type: Growth Capital M&A Deals 88 of 167
Country: United Kingdom M&A 112 of 202
Year: 2019 M&A 16 of 21
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-08-19 Insphere

Bristol, United Kingdom

Insphere is a provider of specialist measurement services, training, and consultancy to manufacturing organizations. Industries such as aerospace, automotive, and defense all employ highly automated manufacturing processes that rely on production lines of robots performing precise and repeatable actions. Measurement technologies have traditionally been used to verify parts at the end of the production line. Insphere was founded in 2013 and is based in Bristol, United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-11-12 Biotherapy Services

London, United Kingdom

Biotherapy Services is a pharmaceutical biotech company used to support the clinical development of RAPIDTM Biodynamic Haematogel, currently in phase 2b/3 clinical trials in the treatment of DFUs. Biotherapy Services was founded in 2013 and is based in London, United Kingdom.

Buy -
Mergr

Solution for

Product

Company

Legal